Loading data
AMPHNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 719.89 m USD | 731.97 m USD | 644.4 m USD | 498.99 m USD | 437.77 m USD |
| Cost of revenue | 363.83 m USD | 358.11 m USD | 293.27 m USD | 250.13 m USD | 238.03 m USD |
| Gross profit | 356.06 m USD | 373.86 m USD | 351.12 m USD | 248.86 m USD | 199.74 m USD |
| Research and development expense | 85.84 m USD | 73.91 m USD | 73.74 m USD | 74.77 m USD | 60.93 m USD |
| Operating profit | 140.4 m USD | 205.42 m USD | 196.99 m USD | 107.5 m USD | 69.89 m USD |
| Interest expense | — | — | 27.16 m USD | 1.85 m USD | 885 k USD |
| Profit before tax | 123.62 m USD | 189.76 m USD | 171.36 m USD | 116.04 m USD | 84.14 m USD |
| Income tax expense | 25.53 m USD | 29.67 m USD | 31.83 m USD | 23.48 m USD | 20.63 m USD |
| Net income (reported basis) | 98.09 m USD | 159.52 m USD | 137.55 m USD | 91.39 m USD | 63.3 m USD |
| Basic earnings per share | 2.1 USD/share | 3.29 USD/share | 2.85 USD/share | 1.88 USD/share | 1.3 USD/share |
| Diluted earnings per share | 2.03 USD/share | 3.06 USD/share | 2.6 USD/share | 1.74 USD/share | 1.25 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.